Clarius Group LLC and other firms have reduced their holdings in Sanofi, potentially impacting the stock price.
🟢 Short-term Forecast: +2.0%
🟢 Long-term Forecast: +1.2%
Stock AI’s (SNY) Forecast get (+10.2% Profit)
StockAI’s analysis delivers real-world results. On 12 January 2024, $SNY ($52.32), StockAI predicted a long-term 🔴 sell signal. It was accurate: 1 month later price dropped to $46.97 (🔴-10.2%). Selling SNY on this signal yielded a +10.2% profit 💰💰.
SNY-Sanofi News
🔴 Clarius Group LLC cut its holdings in shares of Sanofi by 7.9% during the fourth quarter.
🟢 Patten & Patten Inc. TN also cut its holdings in Sanofi by 7.3% during the 4th quarter.
🟢 B. Riley Wealth Advisors Inc. increased its holdings in Sanofi by 25.5% in the third quarter.
🔴 Ingalls & Snyder LLC trimmed its stake in Sanofi by 2.6% in the fourth quarter.
🟢 Pacer Advisors Inc. boosted its holdings in Sanofi by 13.9% in the fourth quarter.
🔴 Synergy Asset Management LLC reduced its holdings in Sanofi by 7.9% in the 4th quarter.
Sanofi stock has seen a mix of positive and negative news recently, with some institutions reducing their holdings while others increasing them. The overall effect on the stock price is uncertain, but it could potentially lead to some short-term volatility. Investors should keep an eye on any further developments and consider the long-term prospects of the company before making any investment decisions.
SNY-Sanofi Analyst Ratings
Analyst Ratings on Sanofi Stock:
📉 Barclays analysts downgraded their rating on Sanofi stock from Equal Weight to Underweight with a target price of $50.
📈 Credit Suisse analysts upgraded their rating on Sanofi stock from Neutral to Outperform and raised the target price from $48 to $55.
📉 Morgan Stanley analysts lowered their rating on Sanofi stock from Overweight to Equal Weight with a target price of $52.
Disclaimer
Investors may consider the AI predictions and news summaries as one factor in their investment decisions alongside their own research and risk tolerance.
Ready to analyze your own portfolio?
Get the same AI-powered insights for any stock you choose. It's easy!
